NYU Langone, New York, NY, USA.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Cephalalgia. 2020 Jun;40(7):712-734. doi: 10.1177/0333102419888230. Epub 2019 Dec 23.
We conducted focus groups in people who had participated in mobile health (mHealth) studies of behavioral interventions for migraine to better understand: (a) Participant experience in the recruitment/enrollment process; (b) participant experience during the studies themselves; (c) ideas for improving participant experience for future studies.
We conducted four focus groups in people who had agreed to participate in one of three studies involving mHealth and behavioral therapy for migraine. Inclusion criteria were being age 18-80, owning a smartphone, and having four or more headache days per month. All participants met the International Classification of Headache Disorders third edition beta version criteria for migraine. Exclusion criteria were not speaking English and having had behavioral therapy for migraine in the past year. Focus groups were audio recorded, fully transcribed and coded using general thematic analysis.
The 12 focus group participants had a mean age of 45 ± 15, a mean age of headache onset of 21 ± 13 and mean MIDAS disability score was 39 ± 56. Participants were women (100%), white (50%), Asian (33.3%) or members of other racial groups (16.7%). Certain themes emerged from each topic area. With regard to recruitment/enrollment (a), key themes were: (i) Participants joined their study out of an interest in research and/or a desire to try a new migraine treatment modality (behavioral therapy) (ii) Enrollment should be simple and study requirements should be carefully explained prior to enrollment. When asked about their experiences during the studies (b), the following themes emerged: (i) It is difficult to participate in study follow-up and compliance phone calls; (ii) participants prefer to choose from among various options for contact with the study team; (iii) there are barriers that limit app use related to migraine itself, as well as other barriers; (iv) completing diaries on a daily basis is challenging; (v) technical difficulties and uncertainties about app features limit use; (vi) being part of a research study promoted daily behavioral therapy use; (vii) progressive muscle relaxation (PMR) is enjoyable, and has a positive impact on life; (viii) behavioral therapy was a preferred treatment to reduce migraine pain. Ideas for improving study design or patient experience (c) included: (i) Increased opportunity to interact with other people with migraine would be beneficial; (ii) navigating the app and data entry should be easier; (iii) more varied methods for viewing the data and measures of adherence are needed; (iv) more information on and more varied behavioral treatment modalities would be preferred.
Though people with migraine are motivated to participate in mHealth and behavioral treatment studies, better communication up front about interventions as well as greater flexibility in interventions and follow-up methods are desired.
我们对参与移动医疗(mHealth)偏头痛行为干预研究的人群进行了焦点小组讨论,以更好地了解:(a)参与者在招募/入组过程中的体验;(b)参与者在研究期间的体验;(c)为改善未来研究中参与者体验的想法。
我们对 3 项 mHealth 和偏头痛行为疗法研究中同意参与其中一项研究的人群进行了 4 次焦点小组讨论。纳入标准为年龄 18-80 岁,拥有智能手机,每月头痛天数为 4 天或以上。所有参与者均符合国际头痛疾病分类第三版β版偏头痛的标准。排除标准为不会说英语和过去一年接受过偏头痛行为治疗。焦点小组全程录音,使用通用主题分析方法进行完整转录和编码。
12 名焦点小组参与者的平均年龄为 45±15 岁,头痛发作的平均年龄为 21±13 岁,平均 MIDAS 残疾评分 39±56。参与者均为女性(100%),白人(50%)、亚洲人(33.3%)或其他种族(16.7%)。每个主题领域都出现了某些主题。关于招募/入组(a),主要主题为:(i)参与者出于对研究的兴趣和/或尝试新的偏头痛治疗方式(行为疗法)的愿望而加入他们的研究;(ii)入组过程应简单,并且在入组前应仔细解释研究要求。当被问及他们在研究期间的体验(b)时,出现了以下主题:(i)参加研究随访和依从性电话很困难;(ii)参与者更愿意从与研究团队联系的各种选项中进行选择;(iii)与偏头痛本身以及其他障碍相关的限制限制了应用程序的使用;(iv)每天填写日记具有挑战性;(v)技术困难和对应用程序功能的不确定性限制了使用;(vi)作为研究的一部分,促进了日常行为疗法的使用;(vii)渐进性肌肉松弛(PMR)令人愉快,并对生活产生积极影响;(viii)行为疗法是减轻偏头痛疼痛的首选治疗方法。关于改善研究设计或患者体验(c)的想法包括:(i)增加与其他偏头痛患者互动的机会将是有益的;(ii)应使应用程序和数据输入更易于操作;(iii)需要更多方法来查看数据和测量依从性;(iv)更需要关于和更多样化的行为治疗模式的信息。
尽管偏头痛患者有动机参与 mHealth 和行为治疗研究,但他们希望在干预措施方面提前进行更好的沟通,并在干预措施和随访方法方面提供更大的灵活性。